Chemicals & Advanced Materials Global On demand · 24-48h

Global Medical Grade Thermoplastic Polyurethanes (TPU) Market Strategic Research Report

Global Medical Grade Thermoplastic Polyurethanes (TPU) Marke…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Grade Thermoplastic Polyurethanes (TPU) Market
$3232025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Pellets and Granules, Films and Sheets, Extruded Tubes and Profiles, Others

By Application: External Communicating Devices, Surface Contact Devices, Short Term Implantable Devices, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Lubrizol Corporation, Covestro AG, BASF SE, Wanhua Chemical Group Co., Ltd., Avient Corporation, GEON Performance Solutions, RTP Company, HEXPOL AB, Huntsman Corporation, ICP DAS Biomedical Polymers, American Polyfilm, Inc., Mativ Holdings, Inc., Permali Gloucester Ltd., UFP Technologies, Inc., Prochase Enterprise Co., Ltd., DingZing Advanced Materials Inc., Zhongshan Breathtex Speciality Material Co., Ltd., Tosoh Corporation

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 138 pages
Market size 2025
$323
Million USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$528.9
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Medical Grade Thermoplastic Polyurethanes (TPU) market size is predicted to grow from US$ 323 million in 2025 to US$ 521 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

Medical grade thermoplastic polyurethane is a high-performance thermoplastic elastomer developed for medical devices, healthcare consumables, and clinical care applications. It is commonly supplied in the form of pellets, granules, films, sheets, tubes, profiles, or compounded materials. Compared with general-purpose industrial TPU, medical grade TPU places greater emphasis on biocompatibility, lot-to-lot consistency, traceability, sterilization resistance, transparency, flexibility, hydrolysis resistance, abrasion resistance, and processing stability. Major material chemistries include polyether-based TPU, polyester-based TPU, and polycarbonate-based TPU.

Medical grade TPU is mainly used in catheters, infusion tubing, dialysis tubing, respiratory and anesthesia tubing, wound-care films, wearable medical patches, flexible medical device components, medical bags, pump tubing, connectors, and short-term contact medical components. Major production and supply regions are concentrated in the United States, Germany, China, Japan, South Korea, and Taiwan, where medical polymer materials, medical devices, and precision processing industries are relatively well developed.

In 2025, global medical grade thermoplastic polyurethane production reached approximately 24.0 thousand to 27.0 thousand tons, with mainstream FOB prices ranging from USD 12,200 to USD 14,200 per ton. The product represents a high-value medical polymer material and is priced significantly above general industrial TPU, mainly due to biocompatibility testing, medical regulatory documentation, batch consistency requirements, clean production management, customer validation cycles, and a higher proportion of high-end medical device applications.

The global medical grade thermoplastic polyurethane market is moving from conventional medical consumable materials toward higher-performance medical functional materials. With the rapid development of minimally invasive intervention, home healthcare, wearable monitoring, chronic disease management, and precision drug delivery devices, medical device manufacturers are increasingly demanding materials that combine flexibility, transparency, kink resistance, sterilization resistance, and strong biocompatibility. Medical grade TPU offers a balanced combination of processing efficiency and clinical safety in catheters, tubing, films, patches, medical bags, and flexible connectors, giving it strong substitution potential against selected PVC, silicone, rubber, and conventional polyolefin materials. In catheters, wound-care films, wearable medical patches, and drug delivery systems, material performance is no longer only a cost factor; it directly affects patient comfort, device reliability, and regulatory efficiency.

At the same time, the market faces high entry barriers and supply-chain risks. Medical grade TPU must not only meet material performance requirements but also support medical device manufacturers through validation processes involving biocompatibility, sterilization compatibility, extractables and leachables, regulatory documentation, long-term supply stability, and change control. Customer switching costs are high, and qualification cycles are long. In the near term, companies in Europe, the United States, and Japan are expected to retain advantages in high-end medical TPU resins, implantable-grade materials, and regulatory support systems, while manufacturers in China, Taiwan, and South Korea are accelerating their presence in films, compounds, medical tubing, and downstream processing. Future growth will be driven more by high-value applications than by simple capacity expansion. Companies that can combine material development, regulatory support, stable mass production, and downstream processing collaboration will be better positioned to enter the core supply chain of global medical device manufacturers.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Grade Thermoplastic Polyurethanes (TPU) market?

What factors are driving Medical Grade Thermoplastic Polyurethanes (TPU) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Grade Thermoplastic Polyurethanes (TPU) market opportunities vary by end market size?

How does Medical Grade Thermoplastic Polyurethanes (TPU) break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Grade Thermoplastic Polyurethanes (TPU) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Pellets and Granules
  • Films and Sheets
  • Extruded Tubes and Profiles
  • Others

Segment by Chemistry

  • Polyether TPU
  • Polyester TPU
  • Polycarbonate TPU
  • Others

Segment by Processing Method

  • Extrusion
  • Injection Molding
  • Film Casting and Calendering
  • Others

Segment by Transparency

  • Transparent Grades
  • Translucent Grades
  • Opaque and Color Matched Grades

Segment by Application

  • External Communicating Devices
  • Surface Contact Devices
  • Short Term Implantable Devices
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Grade Thermoplastic Polyurethanes (TPU) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in External Communicating Devices, Surface Contact Devices, Short Term Implantable Devices evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Grade Thermoplastic Polyurethanes (TPU) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$323
2025
Forecast
$528.9
2032
CAGR
7.3%
2025–2032
Regions
5
global
Key companies
Lubrizol CorporationCovestro AGBASF SEWanhua Chemical Group Co., Ltd.Avient CorporationGEON Performance SolutionsRTP CompanyHEXPOL AB
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Pellets and GranulesFilms and SheetsExtruded Tubes and ProfilesOthers
By Application
External Communicating DevicesSurface Contact DevicesShort Term Implantable DevicesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Pellets and Granules
  • 3.1.3 Films and Sheets
  • 3.1.4 Extruded Tubes and Profiles
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 External Communicating Devices
  • 4.1.3 Surface Contact Devices
  • 4.1.4 Short Term Implantable Devices
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Lubrizol Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Covestro AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BASF SE
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Wanhua Chemical Group Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Avient Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 GEON Performance Solutions
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 RTP Company
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 HEXPOL AB
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Huntsman Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ICP DAS Biomedical Polymers
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 American Polyfilm, Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Mativ Holdings, Inc.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Permali Gloucester Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 UFP Technologies, Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Prochase Enterprise Co., Ltd.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 DingZing Advanced Materials Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Zhongshan Breathtex Speciality Material Co., Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Tosoh Corporation
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Medical Grade Thermoplastic Polyurethanes (TPU) market?
The global Medical Grade Thermoplastic Polyurethanes (TPU) market is estimated at US$ 323 million in 2025 (base year) and is projected to reach US$ 521 million by 2032.
What is the forecast CAGR for the Medical Grade Thermoplastic Polyurethanes (TPU) market?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 323 million in 2025 to US$ 521 million in 2032, roughly 1.6 times its base-year value.
What is Medical Grade Thermoplastic Polyurethanes (TPU)?
Medical grade thermoplastic polyurethane is a high-performance thermoplastic elastomer developed for medical devices, healthcare consumables, and clinical care applications. It is commonly supplied in the form of pellets, granules, films, sheets, tubes, profiles, or compounded materials. Compared with general-purpose industrial TPU, medical grade TPU places greater emphasis on biocompatibility, lot-to-lot consistency, traceability, sterilization resistance, transparency, flexibility, hydrolysis resistance, abrasion resistance, and processing stability.
How is the Medical Grade Thermoplastic Polyurethanes (TPU) market segmented by type?
By type, the market is segmented into Pellets and Granules, Films and Sheets, Extruded Tubes and Profiles and Others.
What are the key applications of Medical Grade Thermoplastic Polyurethanes (TPU)?
Key applications covered include External Communicating Devices, Surface Contact Devices, Short Term Implantable Devices and Others.
Which companies are profiled in the Medical Grade Thermoplastic Polyurethanes (TPU) market report?
Key players profiled include Lubrizol Corporation, Covestro AG, BASF SE, Wanhua Chemical Group Co., Avient Corporation, GEON Performance Solutions, RTP Company and HEXPOL AB, among 18 companies covered in total.
What geographies does the Medical Grade Thermoplastic Polyurethanes (TPU) market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Medical Grade Thermoplastic Polyurethanes (TPU)?
Future growth will be driven more by high-value applications than by simple capacity expansion.
What are the main risks and barriers in the Medical Grade Thermoplastic Polyurethanes (TPU) market?
At the same time, the market faces high entry barriers and supply-chain risks.
Who should buy the Medical Grade Thermoplastic Polyurethanes (TPU) market report?
The report is intended for manufacturers and solution providers, distributors and end users in External Communicating Devices, Surface Contact Devices and Short Term Implantable Devices, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Grade Thermoplastic Polyurethanes (TPU) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.